生命线食品公司拒绝了Danone的2.83亿美元投标,称其价值被低估,并制定了股东权利计划。 Lifeway Foods rejected Danone's $283 million bid, citing it as undervalued, and enacted a shareholder rights plan.

美国Kefir制造商Lifway Foods拒绝Danone的2.83亿美元收购标价, 认为每股25美元的报价被低估。 Lifeway Foods, a US kefir manufacturer, rejected a $283 million takeover bid from Danone, deeming the $25 per share offer as undervalued. 作为回应, " 生命之路 " 实施了股东权利计划,以防止Danone在没有溢价的情况下获取20%以上的股票。 In response, Lifeway implemented a shareholder rights plan to prevent Danone from acquiring more than 20% of its stock without a premium. 虽然Danone目前拥有23.4%的股权,但 " 生命之路 " 的目标是侧重于其战略增长,据2023年创纪录的销售额为1.6亿美元,比上一年增加了13%。 While Danone currently holds a 23.4% stake, Lifeway aims to focus on its strategic growth, having reported record sales of $160 million in 2023, a 13% increase from the previous year.